Semaglutide and cardiovascular outcomes in patients with obesity and heart failure (SELECT)
Other weight loss medications in the same class as Ozempic, glucagon-like peptide-1 (GLP-1) agonists, can also lead to rapid weight loss
This medication helps regulate your appetite, reduce cravings, and improve insulin sensitivity, making it easier to stick to a healthy eating plan
The choice should be based on individual skin condition, health status, personal goals, and professional medical advice to ensure appropriate and safe use
In this real-world setting, patients who were treated with semaglutide 2.4 mg and tirzepatide had a mean weight loss of 14.1% and 16.5% at 1 year, respectively, which represents a clinically meaningful weight loss with both therapies when used in patients with overweight or obesity and without T2DM [20]
However, this primarily reflects a lack of systematic investigation rather than confirmed safety